Search Page

1

Cite

Share

Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.

Keller E, Brandi G, Winklhofer S, Imbach LL, Kirschenbaum D, Frontzek K, Steiger P, Dietler S, Haeberlin M, Willms J, Porta F, Waeckerlin A, Huber M, Abela IA, Lutterotti A, Stippich C, Globas C, Varga Z, Jelcic I. Keller E, et al. Among authors: abela ia. Stroke. 2020 Dec;51(12):3719-3722. doi: 10.1161/STROKEAHA.120.031224. Epub 2020 Oct 15. Stroke. 2020. PMID: 33054673 Free PMC article.

Cite

Share

2

Cite

Share

Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.

Ulyte A, Radtke T, Abela IA, Haile SR, Braun J, Jung R, Berger C, Trkola A, Fehr J, Puhan MA, Kriemler S. Ulyte A, et al. Among authors: abela ia. Int J Public Health. 2020 Dec;65(9):1549-1557. doi: 10.1007/s00038-020-01495-z. Epub 2020 Oct 15. Int J Public Health. 2020. PMID: 33063141 Free PMC article.

Cite

Share

3

Cite

Share

Correlates of broadly neutralizing antibody development.

Abela IA, Kadelka C, Trkola A. Abela IA, et al. Curr Opin HIV AIDS. 2019 Jul;14(4):279-285. doi: 10.1097/COH.0000000000000552. Curr Opin HIV AIDS. 2019. PMID: 31107283 Free article. Review.

Cite

Share

4

Cite

Share

Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office.

Weissberg D, Böni J, Rampini SK, Kufner V, Zaheri M, Schreiber PW, Abela IA, Huber M, Sax H, Wolfensberger A. Weissberg D, et al. Among authors: abela ia. Antimicrob Resist Infect Control. 2020 Dec 2;9(1):191. doi: 10.1186/s13756-020-00861-z. Antimicrob Resist Infect Control. 2020. PMID: 33267855 Free PMC article.

Cite

Share

5

Cite

Share

Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients.

Abela IA, Scherrer AU, Böni J, Yerly S, Klimkait T, Perreau M, Hirsch HH, Furrer H, Calmy A, Schmid P, Cavassini M, Bernasconi E, Günthard HF; Swiss HIV Cohort Study. Abela IA, et al. Clin Infect Dis. 2020 Jan 2;70(2):297-303. doi: 10.1093/cid/ciz178. Clin Infect Dis. 2020. PMID: 30843028

Cite

Share

6

Cite

Share

Therapeutic antibodies in HIV treatment--classical approaches to novel advances.

Abela IA, Reynell L, Trkola A. Abela IA, et al. Curr Pharm Des. 2010;16(33):3754-66. doi: 10.2174/138161210794079245. Curr Pharm Des. 2010. PMID: 21128888 Review.

Cite

Share

7

Cite

Share

A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.

Abela IA, Murer C, Schuurmans MM, Schmitt JW, Muller F, Imkamp F, Mueller NJ, Benden C. Abela IA, et al. Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12792. Epub 2017 Nov 27. Transpl Infect Dis. 2018. PMID: 29044831 Review.

Cite

Share

8

Cite

Share

CardioPulse: Mentoring young physician-scientists. A Position and Practice Guide by a Young MD/PhD and a Department Head.

Abela IA, Beer JH. Abela IA, et al. Eur Heart J. 2016 Mar 1;37(9):735-7. Eur Heart J. 2016. PMID: 27366801 No abstract available.

Cite

Share

9

Cite

Share

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1.

Ruprecht CR, Krarup A, Reynell L, Mann AM, Brandenberg OF, Berlinger L, Abela IA, Regoes RR, Günthard HF, Rusert P, Trkola A. Ruprecht CR, et al. Among authors: abela ia. J Exp Med. 2011 Mar 14;208(3):439-54. doi: 10.1084/jem.20101907. Epub 2011 Feb 28. J Exp Med. 2011. PMID: 21357743 Free PMC article.

Cite

Share

10

Cite

Share

Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Abela IA, Berlinger L, Schanz M, Reynell L, Günthard HF, Rusert P, Trkola A. Abela IA, et al. PLoS Pathog. 2012;8(4):e1002634. doi: 10.1371/journal.ppat.1002634. Epub 2012 Apr 5. PLoS Pathog. 2012. PMID: 22496655 Free PMC article. Clinical Trial.

Cite

Share